Investors Are Bullish On This Pot Stock: Should You Drop Tilray Inc (TLRY) Wednesday?

TLRY stock is higher by 1.64% Wednesday as the pot stock increases $0.07 and outperforms the market. Overall market sentiment has been high on Tilray Inc (TLRY) stock lately. TLRY receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Tilray Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TLRY!

See Full TLRY Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TLRY Stock Today?

Tilray Inc (TLRY) stock is trading at $4.27 as of 9:57 AM on Wednesday, Aug 17, a rise of $0.07, or 1.64% from the previous closing price of $4.20. The stock has traded between $4.10 and $4.30 so far today. Volume today is below average. So far 3,755,995 shares have traded compared to average volume of 31,038,903 shares. To screen for more stocks like Tilray Inc click here.

More About Tilray Inc

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Click Here to get the full Stock Report for Tilray Inc stock.